Clinical Trial Update: Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing an oral valsartan/amlodipine combination to amlodipine monotherapy in Black patients with stage II hypertension has completed, evaluatin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Exforge (valsartan; amlodipine)
• NORVASC (amlodipine besylate)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED